151 related articles for article (PubMed ID: 6304814)
1. Piribedil: behavioural, neurochemical and clinical profile of a dopamine agonist.
Dourish CT
Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(1):3-27. PubMed ID: 6304814
[No Abstract] [Full Text] [Related]
2. Yawning elicited by systemic and intrastriatal injection of piribedil and apomorphine in the rat.
Dourish CT; Cooper SJ; Philips SR
Psychopharmacology (Berl); 1985; 86(1-2):175-81. PubMed ID: 2991964
[TBL] [Abstract][Full Text] [Related]
3. The development of responsiveness to dopaminergic agonists.
Reinstein DK; McClearn D; Isaacson RL
Brain Res; 1978 Jul; 150(1):216-23. PubMed ID: 566610
[No Abstract] [Full Text] [Related]
4. Differentiation of apomorphine from bromocriptine, piribidel and TRH by chronic administration in rats.
Porreca F; Cowan A; Tallarida RJ
Psychopharmacology (Berl); 1982; 76(1):70-4. PubMed ID: 6805012
[No Abstract] [Full Text] [Related]
5. [Facilitation of a stereotyped motor behavior (climbing behavior) by previous stimulation of dopaminergic receptors: hyposensitivity of autoreceptors?].
Costentin J; Marçais H; Protais P; Baudry M; Martres MP; Schwartz JC
C R Acad Hebd Seances Acad Sci D; 1977 Jan; 284(2):143-6. PubMed ID: 402241
[TBL] [Abstract][Full Text] [Related]
6. Reduction of food intake by piribedil in the rat: relation to dopamine receptor stimulation.
Carruba MO; Ricciardi S; Mantegazza P
Life Sci; 1980 Sep; 27(13):1131-40. PubMed ID: 6252402
[No Abstract] [Full Text] [Related]
7. Piribedil and apomorphine: pre- and postsynaptic effects on dopamine synthesis and neuronal activity.
Walters JR; Bunney BS; Roth RH
Adv Neurol; 1975; 9():273-84. PubMed ID: 167566
[TBL] [Abstract][Full Text] [Related]
8. Apomorphine and piribedil in rats: biochemical and pharmacologic studies.
Butterworth RF; Poignant JC; Barbeau A
Adv Neurol; 1975; 9():307-26. PubMed ID: 1170716
[TBL] [Abstract][Full Text] [Related]
9. Reversible effects of low doses of tetanus toxin on synaptic inhibition in the substantia nigra and turning behaviour in the rat.
Collingridge GL; Davies J
Brain Res; 1980 Mar; 185(2):455-9. PubMed ID: 7188876
[No Abstract] [Full Text] [Related]
10. Possible mechanisms involved in the stereotyped behavior elicited by amphetamine.
Groves PM
Biol Psychiatry; 1977 Jun; 12(3):381-8. PubMed ID: 194632
[TBL] [Abstract][Full Text] [Related]
11. Interactions of exogenous L-dopa with nigrostriatal dopaminergic neurons in Parkinson's disease.
Melamed E
Adv Neurol; 1990; 53():61-6. PubMed ID: 2173376
[No Abstract] [Full Text] [Related]
12. Neurochemical effects of ET 495 : mechanism of action.
Hiremagalur J; Keshavan H; Gurbani NK; Dandiya PC
Pharmacol Res Commun; 1981 Jun; 13(6):607-15. PubMed ID: 6170078
[No Abstract] [Full Text] [Related]
13. [Dopamine agonists in the therapy of parkinson syndrome].
Kapfhammer HP; Rüther E
Nervenarzt; 1985 Feb; 56(2):69-81. PubMed ID: 3982566
[No Abstract] [Full Text] [Related]
14. Dopaminergic D2 receptor is a key player in the substantia nigra pars compacta neuronal activation mediated by REM sleep deprivation.
Proença MB; Dombrowski PA; Da Cunha C; Fischer L; Ferraz AC; Lima MM
Neuropharmacology; 2014 Jan; 76 Pt A():118-26. PubMed ID: 24012539
[TBL] [Abstract][Full Text] [Related]
15. Experimental basis of the therapy of Parkinson's disease and the cholinergic-dopaminergic equilibrium in basal brain nuclei.
Wolfarth S
Pol J Pharmacol Pharm; 1976; 28(5):469-93. PubMed ID: 796834
[No Abstract] [Full Text] [Related]
16. Non-cholinergic action of exogenous acetylcholinesterase in the rat substantia nigra. II. Long-term interactions with dopamine metabolism.
Hawkins CA; Greenfield SA
Behav Brain Res; 1992 Jun; 48(2):159-63. PubMed ID: 1616606
[TBL] [Abstract][Full Text] [Related]
17. Evidence that nigral GABA mediates behavioural responses elicited by striatal dopamine receptor stimulation.
Di Chiara G; Morelli M; Porceddu ML; Gessa GL
Life Sci; 1978 Nov; 23(20):2045-51. PubMed ID: 569236
[No Abstract] [Full Text] [Related]
18. Behavioural evidence of dopamine receptor stimulation by piribedil (ET495) and its metabolite S584.
Creese I
Eur J Pharmacol; 1974 Sep; 28(1):55-8. PubMed ID: 4473347
[No Abstract] [Full Text] [Related]
19. Effects of piribedil and of d-amphetamine on locomotor activity in immature rats.
Dourish CT; Cooper SJ
Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(2):249-55. PubMed ID: 6539932
[TBL] [Abstract][Full Text] [Related]
20. Behavioral supersensitivity to beta-phenylethylamine after chronic administration of haloperidol.
Stoff DM; Jeste DV; Gillin JC; Moja EA; Cohen L; Stauderman KA; Wyatt RJ
Biol Psychiatry; 1984 Jan; 19(1):101-6. PubMed ID: 6538440
[No Abstract] [Full Text] [Related]
[Next] [New Search]
